4IMA
| The structure of C436M-hLPYK in complex with Citrate/Mn/ATP/Fru-1,6-BP | Descriptor: | 1,2-ETHANEDIOL, 1,6-di-O-phosphono-beta-D-fructofuranose, ADENOSINE, ... | Authors: | Zhang, B, Holyoak, T, Fenton, A.W, Tang, Q.L, Prasannan, C.B, Deng, J.P. | Deposit date: | 2013-01-02 | Release date: | 2013-01-23 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (1.954 Å) | Cite: | Energetic Coupling between an Oxidizable Cysteine and the Phosphorylatable N-Terminus of Human Liver Pyruvate Kinase. Biochemistry, 52, 2013
|
|
7EU9
| Crystal structure of the selenomethionine(SeMet)-derived Cas12i1 R-loop complex before target DNA cleavage | Descriptor: | CITRIC ACID, Cas12i1 D647A mutant, DNA (24-MER), ... | Authors: | Zhang, B, Luo, D.Y, Li, Y, OuYang, S.Y. | Deposit date: | 2021-05-16 | Release date: | 2021-05-26 | Last modified: | 2021-06-23 | Method: | X-RAY DIFFRACTION (2.35 Å) | Cite: | Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1. Nat Commun, 12, 2021
|
|
5XNW
| |
7VRK
| crystal structure of BRD2-BD1 in complex with purine derivative | Descriptor: | Bromodomain-containing protein 2, SULFATE ION, THEOPHYLLINE | Authors: | Padmanabhan, B, Arole, A, Deshmukh, P, Ashok, S, Mathur, S. | Deposit date: | 2021-10-23 | Release date: | 2023-02-01 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.48 Å) | Cite: | Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol, 79, 2023
|
|
7ZH6
| |
7ZHA
| |
1M27
| Crystal structure of SAP/FynSH3/SLAM ternary complex | Descriptor: | CITRATE ANION, Proto-oncogene tyrosine-protein kinase FYN, SH2 domain protein 1A, ... | Authors: | Chan, B, Griesbach, J, Song, H.K, Poy, F, Terhorst, C, Eck, M.J. | Deposit date: | 2002-06-21 | Release date: | 2003-05-06 | Last modified: | 2024-02-14 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | SAP couples Fyn to SLAM immune receptors. NAT.CELL BIOL., 5, 2003
|
|
2KZC
| Solution NMR structure of the protein YP_510488.1 | Descriptor: | Uncharacterized protein | Authors: | Mohanty, B, Serrano, P, Geralt, M, Horst, R, Wilson, I.A, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2010-06-15 | Release date: | 2010-07-14 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Solution NMR structure of the protein YP_510488.1 To be Published
|
|
7VMX
| |
6BI6
| Solution NMR structure of uncharacterized protein YejG | Descriptor: | Uncharacterized protein YejG | Authors: | Mohanty, B, Finn, T.J, Macindoe, I, Zhong, J, Patrick, W.M, Mackay, J.P. | Deposit date: | 2017-11-01 | Release date: | 2018-11-07 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | The uncharacterized bacterial protein YejG has the same architecture as domain III of elongation factor G. Proteins, 87, 2019
|
|
2LA3
| The NMR structure of the protein NP_344798.1 reveals a CCA-adding enzyme head domain | Descriptor: | Uncharacterized protein | Authors: | Mohanty, B, Serrano, P, Geralt, M, Horst, R, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2011-03-01 | Release date: | 2011-03-30 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Solution NMR structure of the protein NP_344798.1 To be Published
|
|
2L1N
| Solution NMR structure of the protein YP_399305.1 | Descriptor: | Uncharacterized protein | Authors: | Mohanty, B, Serrano, P, Geralt, M, Horst, R, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2010-07-30 | Release date: | 2010-08-18 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Solution NMR structure of the protein YP_399305.1 To be Published
|
|
2YXG
| |
2L9D
| Solution structure of the protein YP_546394.1, the first structural representative of the pfam family PF12112 | Descriptor: | Uncharacterized protein | Authors: | Mohanty, B, Serrano, P, Geralt, M, Horst, R, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2011-02-08 | Release date: | 2011-03-16 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Solution structure of the protein YP_546394.1, the first structural representative of the pfam family PF12112 To be Published
|
|
2KL4
| NMR structure of the protein NB7804A | Descriptor: | BH2032 protein | Authors: | Mohanty, B, Geralt, M, Augustyniak, W, Serrano, P, Horst, R, Wilson, I.A, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2009-06-30 | Release date: | 2009-07-14 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Solution structure of the protein NB7804A from Bacillus Halodurans To be Published
|
|
2L6N
| NMR solution structure of the protein YP_001092504.1 | Descriptor: | uncharacterized protein YP_001092504.1 | Authors: | Mohanty, B, Serrano, P, Geralt, M, Horst, R, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2010-11-23 | Release date: | 2011-01-19 | Last modified: | 2024-05-01 | Method: | SOLUTION NMR | Cite: | NMR solution structure of the protein YP_001092504.1 To be Published
|
|
2L6P
| NMR solution structure of the protein NP_253742.1 | Descriptor: | PhaC1, phaC2 and phaD genes | Authors: | Mohanty, B, Serrano, P, Geralt, M, Horst, R, Wuthrich, K, Joint Center for Structural Genomics (JCSG) | Deposit date: | 2010-11-23 | Release date: | 2011-01-19 | Last modified: | 2024-05-01 | Method: | SOLUTION NMR | Cite: | NMR solution structure of the protein NP_253742.1 To be Published
|
|
2Z32
| |
7VOK
| |
5XHK
| Crystal structure of the BRD2-BD2 in complex with phenanthridinone | Descriptor: | Bromodomain-containing protein 2, GLYCEROL, METHOXYETHANE, ... | Authors: | Padmanabhan, B, Mathur, S, Tripathi, S, Deshmukh, P. | Deposit date: | 2017-04-21 | Release date: | 2017-09-06 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (1.28 Å) | Cite: | Insights into the crystal structure of BRD2-BD2 - phenanthridinone complex and theoretical studies on phenanthridinone analogs. J. Biomol. Struct. Dyn., 36, 2018
|
|
7VRH
| crystal structure of BRD2-BD1 in complex with guanosine analog | Descriptor: | 2,3-DIHYDROXY-1,4-DITHIOBUTANE, 9-HYROXYETHOXYMETHYLGUANINE, Bromodomain-containing protein 2, ... | Authors: | Padmanabhan, B, Arole, A, Deshmukh, P, Ashok, S, Mathur, S. | Deposit date: | 2021-10-22 | Release date: | 2023-02-01 | Last modified: | 2023-08-16 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol, 79, 2023
|
|
7VRO
| crystal structure of BRD2-BD1 in complex with purine derivative | Descriptor: | Bromodomain-containing protein 2, SULFATE ION, THEOBROMINE | Authors: | Padmanabhan, B, Arole, A, Deshmukh, P, Ashok, S, Mathur, S. | Deposit date: | 2021-10-23 | Release date: | 2023-02-01 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.35 Å) | Cite: | Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol, 79, 2023
|
|
7VSF
| crystal structure of BRD2-BD1 in complex with purine derivative | Descriptor: | 3-methyl-7-propyl-purine-2,6-dione, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, Bromodomain-containing protein 2, ... | Authors: | Padmanabhan, B, Arole, A, Deshmukh, P, Ashok, S, Mathur, S. | Deposit date: | 2021-10-26 | Release date: | 2023-02-01 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol, 79, 2023
|
|
7VRZ
| crystal structure of BRD2-BD1 in complex with purine derivative | Descriptor: | Bromodomain-containing protein 2, Doxofylline, SULFATE ION | Authors: | Padmanabhan, B, Arole, A, Deshmukh, P, Ashok, S, Mathur, S. | Deposit date: | 2021-10-25 | Release date: | 2023-02-01 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (2.05 Å) | Cite: | Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol, 79, 2023
|
|
7C5E
| Crystal structure of Keap1 in complex with fumarate (FUM) | Descriptor: | ACETATE ION, FUMARIC ACID, Kelch-like ECH-associated protein 1, ... | Authors: | Padmanabhan, B, Unni, S, Deshmukh, P. | Deposit date: | 2020-05-19 | Release date: | 2020-08-05 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.75 Å) | Cite: | Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1. Febs J., 288, 2021
|
|